High-density lipoprotein prevents SAA-induced production of TNF-α in THP-1 monocytic cells and peripheral blood mononuclear cells

Memorias do Instituto Oswaldo Cruz

Volumn 106, Issue 8, 2011, Pages 986-992

  Franco, Andressa Grecco ^a   Sandri, Silvana ^a   Campa, Ana ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Human serum; Lipoprotein deficient serum; Peripheral blood mononuclear cells; Proinflammatory cytokines; Serum amyloid A; THP 1 monocytic lineage

Indexed keywords

EID: 84855491389     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762011000800014     Document Type: Article

References (45)

1. Badolato R, Wang J, Murphy W, Lloyd A, Michiel D, Bausserman L, Kelvin D, Oppenheim J 1994. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 180: 203-209.
2. Baranova I, Bocharov A, Vishnyakova T, Kurlander R, Chen Z, Fu D, Arias I, Csako G, Patterson A, Eggerman T 2010. CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signalling in human and rodent cells. J Biol Chem 285: 8492-8506.
3. Barter P, Nicholls S, Rye K, Anantharamaiah G, Navab M, Fogelman A 2004. Antiinflammatory properties of HDL. Circ Res 95: 764-772.
4. Bausserman LL, Herbert PN, Forte T, Klausner RD, McAdam KP, Osborne JC, Rosseneu M 1983. Interaction of the serum amyloid A proteins with phospholipid. J Biol Chem 258: 10681-10688.
5. Boyum A 1974. Separation of blood leucocytes, granulocytes and lymphocytes. Tissue Antigens 4: 269-274.
6. Cai H, Song C, Endoh I, Goyette J, Jessup W, Freedman S, McNeil H, Geczy C 2007. Serum amyloid A induces monocyte tissue factor. J Immunol 178: 1852-1860.
7. Cockerill G, Rye K, Gamble J, Vadas M, Barter P 1995. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 15: 1987-1994.
8. De Santo C, Arscott R, Booth S, Karydis I, Jones, Asher R, Salio M, Middleton M, Cerundolo V 2010. Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nat Immunol 11: 1039-1046.
9. Fantuzzi G 2005. Adipose tissue, adipokines and inflammation. J Allergy Clin Immunol 115: 911-919.
10. Furlaneto C, Campa A 2000. A novel function of serum amyloid A: a potent stimulus for the release of tumour necrosis factor-alpha, interleukin-1 beta and interleukin-8 by human blood neutrophil. Biochem Biophys Res Commun 268: 405-408.
11. Grunfeld C, Marshall M, Shigenaga J, Moser A, Tobias P, Feingold K 1999. Lipoproteins inhibit macrophage activation by lipoteichoic acid. J Lipid Res 40: 245-252.
12. Gutfeld O, Prus D, Ackerman Z, Dishon S, Linke R, Levin M, Urieli-Shoval S 2006. Expression of serum amyloid A, in normal, dysplastic and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis. J Histochem Cytochem 54: 63-73.
13. Hamann L, Alexander C, Stamme C, Zähringer U, Schumann RR 2005. Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms. Infect Immun 73: 193-200.
14. Hatanaka E, Furlaneto C, Ribeiro F, Souza G, Campa A 2004. Serum amyloid A-induced mRNA expression and release of tumour necrosis factor-alpha (TNF-alpha) in human neutrophils. Immunol Lett 91: 33-37.
15. Hatanaka E, Ribeiro FP, Campa A 2003. The acute phase protein serum amyloid A primes neutrophils. FEMS Immunol Med Microbiol 38: 81-84.
16. Havel RJ, Eder HA, Bragdon JH 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353.
17. Kinkley SM, Bagshaw WL, Tam SP, Kisilevsky R 2006. The path of murine serum amyloid A through peritoneal macrophages. Amyloid 13: 123-134.
18. Libby P 2002. Inflammation in atherosclerosis. Nature 420: 868-874.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
20. Mackness M, Durrington P, Mackness B 2000. How high-density lipoprotein protects against the effects of lipid peroxidation. Curr Opin Lipidol 11: 383-388.
21. Malle E, De Beer FC 1996. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 26: 427-435.
22. Marhaug G, Sletten K, Husby G 1982. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA). Clin Exp Immunol 50: 382-389.
23. Massamiri T, Tobias PS, Curtiss LK 1997. Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I. J Lipid Res 38: 516-525.
24. Meek R, Urieli-Shoval S, Benditt E 1994. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci USA 91: 3186-3190.
25. Munford R, Hall C, Lipton J, Dietschy J 1982. Biological activity, lipoprotein-binding behaviour and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J Clin Invest 70: 877-888.
26. Murch O, Collin M, Hinds C, Thiemermann C 2007. Lipoproteins in inflammation and sepsis. I. Basic science. Intensive Care Med 33: 13-24.
27. Naiko NK 2003. Coronary artery disease and disorders of lipid metabolism. In LA Kaplan, AJ Pesce, SC Kazmierczak (eds.), Clinical chemistry: theory, analysis, correlation, Mosby, St. Louis, p. 603-638.
28. Nanjee MN, Cooke CJ, Olszewski WL, Miller NE 2000. Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph. Arterioscler Thromb Vasc Biol 20: 2148-2155.
29. O'Hara R, Murphy E, Whitehead A, Fitzgerald O, Bresnihan B 2004. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum 50: 1788-1799.
30. Okino AM, Bürger C, Cardoso JR, Lavado EL, Lotufo PA, Campa A 2006. The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates. Mediators Inflamm 2006: 47297.
31. Poitou C, Viguerie N, Cancello R, De Matteis R, Cinti S, Stich V, Coussieu C, Gauthier E, Courtine M, Zucker J, Barsh G, Saris W, Bruneval P, Basdevant A, Langin D, Clément K 2005. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia 48: 519-528.
32. Ribeiro F, Furlaneto C, Hatanaka E, Ribeiro W, Souza G, Cassatella M, Campa A 2003. mRNA expression and release of interleukin-8 induced by serum amyloid A in neutrophils and monocytes. Mediators Inflam 12: 173-178.
33. Sandri S, Hatanaka E, Franco A, Pedrosa A, Monteiro H, Campa A 2008a. Serum amyloid A induces CCL20 secretion in mononuclear cells through MAPK (p38 and ERK1/2) signaling pathways. Immunol Lett 121: 22-26.
34. Sandri S, Rodriguez D, Gomes E, Monteiro H, Russo M, Campa A 2008b. Is serum amyloid A an endogenous TLR4 agonist? J Leukoc Biol 83: 1174-1180.
35. Song C, Hsu K, Yamen E, Yan W, Fock J, Witting PK, Geczy CL, Freedman SB 2009a. Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. Atherosclerosis 207: 374-383.
36. Song C, Shen Y, Yamen E, Hsu K, Yan W, Witting PK, Geczy CL, Freedman SB 2009b. Serum amyloid A may potentiate prothrombotic and proinflammatory events in acute coronary syndromes. Atherosclerosis 202: 596-604.
37. Uhlar C, Whitehead A 1999. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265: 501-523.
38. Urieli-Shoval S, Meek RL, Hanson RH, Eriksen N, Benditt EP 1994. Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am J Pathol 145: 650-660.
39. Wadham C, Albanese N, Roberts J, Wang L, Bagley C, Gamble J, Rye K, Barter P, Vadas M, Xia P 2004. High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation 109: 2116-2122.
40. Wu A, Hinds CJ, Thiemermann C 2004. High-density lipoproteins in sepsis and septic shock: metabolism, actions and therapeutic applications. Shock 21: 210-221.
41. Yamada T, Kakihara T, Kamishima T, Fukuda T, Kawai T 1996. Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions. Pathol Int 46: 797-800.
42. Yang R, Lee M, Hu H, Pollin T, Ryan A, Nicklas B, Snitker S, Horenstein R, Hull K, Goldberg N, Goldberg A, Shuldiner A, Fried S, Gong D 2006. Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 3: e287.
43. Yuhanna I, Zhu Y, Cox B, Hahner L, Osborne-Lawrence S, Lu P, Marcel Y, Anderson R, Mendelsohn M, Hobbs H, Shaul P 2001. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med 7: 853-857.
44. Zanotti S, Kumar A 2002. Cytokine modulation in sepsis and septic shock. Expert Opin Investig Drugs 11: 1061-1075.
45. Zarember KA, Godowski PJ 2002. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products and cytokines. J Immunol 168: 554-561.